Isracann Biosciences Grants Stock Options and Enters into a Marketing Agreement
VANCOUVER, BC, — (November 6, 2019) – Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) has granted a total of 3,500,000 stock options to certain officers, directors, consultants and an investor relations provider of the Company pursuant to the Company’s stock option plan. The stock options may be exercised at a price...